These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32544925)

  • 1. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
    Pizzagalli DA; Smoski M; Ang YS; Whitton AE; Sanacora G; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu DV; Murrough JW; Yang H; Weiner RD; Calabrese JR; Goodman W; Potter WZ; Krystal AD
    Neuropsychopharmacology; 2020 Sep; 45(10):1656-1663. PubMed ID: 32544925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.
    Krystal AD; Pizzagalli DA; Smoski M; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu D; Murrough JW; Yang H; Weiner RD; Calabrese JR; Sanacora G; Hermes G; Keefe RSE; Song A; Goodman W; Szabo ST; Whitton AE; Gao K; Potter WZ
    Nat Med; 2020 May; 26(5):760-768. PubMed ID: 32231295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using latent profile analyses to classify subjects with anhedonia based on reward-related measures obtained in the FAST-MAS study.
    Darrow SM; Pizzagalli DA; Smoski M; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu D; Murrough JW; Yang H; Weiner RD; Sanacora G; Keefe RSE; Song A; Goodman W; Whitton AE; Potter WZ; Krystal AD
    J Affect Disord; 2023 Oct; 339():584-592. PubMed ID: 37467805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aticaprant, a kappa opioid receptor antagonist, and the recovered 'interest and pleasure' in the concept of major depressive disorder.
    Demyttenaere K
    Eur Arch Psychiatry Clin Neurosci; 2024 Jul; ():. PubMed ID: 38969753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
    Pizzagalli DA; Smoski M; Ang YS; Whitton AE; Sanacora G; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu DV; Murrough JW; Yang H; Weiner RD; Calabrese JR; Goodman W; Potter WZ; Krystal AD
    Neuropsychopharmacology; 2021 Nov; 46(12):2224. PubMed ID: 34389811
    [No Abstract]   [Full Text] [Related]  

  • 6. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.
    Browne CA; Wulf H; Lucki I
    Handb Exp Pharmacol; 2022; 271():493-524. PubMed ID: 33580854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology.
    Corral-Frías NS; Nikolova YS; Michalski LJ; Baranger DA; Hariri AR; Bogdan R
    Psychol Med; 2015; 45(12):2605-17. PubMed ID: 25853627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-species assay demonstrates that reward responsiveness is enduringly impacted by adverse, unpredictable early-life experiences.
    Kangas BD; Short AK; Luc OT; Stern HS; Baram TZ; Pizzagalli DA
    Neuropsychopharmacology; 2022 Feb; 47(3):767-775. PubMed ID: 34921225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and dimensional evaluation of implicit reward learning in social anxiety disorder and major depression.
    Reilly EE; Whitton AE; Pizzagalli DA; Rutherford AV; Stein MB; Paulus MP; Taylor CT
    Depress Anxiety; 2020 Dec; 37(12):1221-1230. PubMed ID: 32906219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task.
    Pizzagalli DA; Iosifescu D; Hallett LA; Ratner KG; Fava M
    J Psychiatr Res; 2008 Nov; 43(1):76-87. PubMed ID: 18433774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
    Carlezon WA; Krystal AD
    Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis.
    Pirino BE; Spodnick MB; Gargiulo AT; Curtis GR; Barson JR; Karkhanis AN
    Neuropharmacology; 2020 Dec; 181():108341. PubMed ID: 33011200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task.
    Pizzagalli DA; Goetz E; Ostacher M; Iosifescu DV; Perlis RH
    Biol Psychiatry; 2008 Jul; 64(2):162-8. PubMed ID: 18242583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anhedonia in melancholic and non-melancholic depressive disorders.
    Fletcher K; Parker G; Paterson A; Fava M; Iosifescu D; Pizzagalli DA
    J Affect Disord; 2015 Sep; 184():81-8. PubMed ID: 26074016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
    Jackson KJ; Carroll FI; Negus SS; Damaj MI
    Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a diurnal rhythm in implicit reward learning.
    Whitton AE; Mehta M; Ironside ML; Murray G; Pizzagalli DA
    Chronobiol Int; 2018 Aug; 35(8):1104-1114. PubMed ID: 29688082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological signatures of reward learning in the rodent touchscreen-based Probabilistic Reward Task.
    Iturra-Mena AM; Kangas BD; Luc OT; Potter D; Pizzagalli DA
    Neuropsychopharmacology; 2023 Mar; 48(4):700-709. PubMed ID: 36646816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhedonia and anxiety underlying depressive symptomatology have distinct effects on reward-based decision-making.
    Harlé KM; Guo D; Zhang S; Paulus MP; Yu AJ
    PLoS One; 2017; 12(10):e0186473. PubMed ID: 29059254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced reward learning predicts outcome in major depressive disorder.
    Vrieze E; Pizzagalli DA; Demyttenaere K; Hompes T; Sienaert P; de Boer P; Schmidt M; Claes S
    Biol Psychiatry; 2013 Apr; 73(7):639-45. PubMed ID: 23228328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.